Skip to main content
logo
BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.820
-0.040 (-1.40%)
Jul 24, 2026, 4:00 PM EDT - Market closed

BioLineRx Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.931.1828.944.8--
Revenue Growth
-95.86%-95.92%502.92%---
Gross Profit
1.110.9519.681.11--
Operating Income
-10.9-10.29-20.41-49.69-29.16-24.78
Net Income
-1.6-2.03-9.22-60.61-24.95-27.05
Earnings Per Share
---6.00-36.00-18.00-24.00
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
China
-14.964.61
U.s.
1.1813.980.19
Total
1.1828.944.8

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.3520.8819.5642.9951.0857.14
Total Debt
9.0710.1515.0411.5912.324.65
Net Cash (Debt)
8.2810.734.5231.438.7652.48
Net Cash Growth
-34.40%137.20%-85.60%-18.98%-26.15%252.17%
Net Cash Per Share
1.932.612.2619.5630.0547.50

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.76-8.07-43.87-22.61-26.24-23.57
Capital Expenditures
--0.03-0.05-0.12-0.13-0.1
Free Cash Flow
-7.76-8.1-43.93-22.72-26.37-23.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
120.11%80.51%67.99%23.08%--
Operating Margin
-1178.38%-871.78%-70.52%-1035.29%--
Pretax Margin
-1053.08%-171.69%-31.86%-1262.79%--
Profit Margin
-279.78%-171.69%-31.86%-1262.79%--
FCF Margin
-839.24%-686.36%-151.78%-473.42%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.219.650.5923.69--